Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.

Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW.

Breast Cancer Res Treat. 2011 Sep;129(2):549-56. doi: 10.1007/s10549-011-1505-3. Epub 2011 Apr 11.

PMID:
21479924
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
[PubMed - indexed for MEDLINE]
3.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
[PubMed - indexed for MEDLINE]
4.

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL.

BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008. Review.

PMID:
24157497
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk